Advertisement

Topics

Latest "Arquer Diagnostics Ltd" News Stories

20:54 EST 22nd November 2017 | BioPortfolio

Here are the most relevant search results for "Arquer Diagnostics Ltd" found in our extensive news archives from over 250 global news sources.

More Information about Arquer Diagnostics Ltd on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Arquer Diagnostics Ltd for you to read. Along with our medical data and news we also list Arquer Diagnostics Ltd Clinical Trials, which are updated daily. BioPortfolio also has a large database of Arquer Diagnostics Ltd Companies for you to search.

Showing "Arquer Diagnostics" News Articles 1–25 of 2,700+

Wednesday 22nd November 2017

Athera Biotechnologies AB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14112017] Prices from USD $250

SummaryAthera Biotechnologies AB Athera is a biopharmaceutical company that develops targeted anti inflammatory biological candidate drugs and companion diagnostics for cardiovascular disease. The company's product includes PCmAb, which is a fully human monoclonal antibody that neutralizes a key driver of vascular inflammation, phosphorylcholine. It has developed a proprietary companion diagnostic...


US Hemostasis Diagnostics Market 2021: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers [Report Updated: 15112017] Prices from USD $9600

Complete report $9,600. nbsp;DataPack test volumes, sales forecasts, supplier shares $6,200.SummaryThis comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years.The report explores business and technological trends ...

Spain Hemostasis Diagnostics Market 2021: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers [Report Updated: 15112017] Prices from USD $6100

Complete report $6,100. nbsp;DataPack test volumes, sales forecasts, supplier shares $3,950.SummaryThis comprehensive report contains 400 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Spanish coagulation testing market during the next five years.The report explores business and technological tr...


Physician Office Diagnostics Market 2021: Supplier Shares, Volume and Sales Forecasts for 300 Tests, Competitive Strategies, Innovative Technologies, Instrumentation Review [Report Updated: 15112017] Prices from USD $12500

This 970page report provides comprehensive analysis of the physician office/group practice diagnostics market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.This report will help diagnostic reagent and instrument suppliers develop more effective business, Ramp;D and mark...

Global Antibody Market Data List by Segment 20152022 [Report Updated: 06112017] Prices from USD $800

SnapshotIn Vitro Diagnostics IVD are tests used to detect disease, infections and other medical conditions. IVD antibodies are widely used for immunology methods such as immunonephelometry and sandwich ELISA.This report covers Antibody basic market data by segment:1 by Product2 by EndUser3 by Company4 by Region5 by Channel6 by PriceThis report can also be customized according to further requiremen...

Lab21 Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 08112017] Prices from USD $250

SummaryLab21 Ltd Lab21, a subsidiary of Novacyt SA is a clinical laboratory that provides clinical diagnostic testing services. The company develops molecular diagnostics for oncology, HIV and viral hepatitis, drug management needs; and diagnostic kits and reagents including syphilis, malaria, human cytomegalovirus, blood donor screening, virology, enzyme immunoassay, bulk material, febrile staine...

Anteo Diagnostics Ltd ADO Medical Equipment Deals and Alliances Profile [Report Updated: 15112017] Prices from USD $250

SummaryAnteo Diagnostics Ltd Anteo Diagnostics is a medical technology company that develops and commercializes healthcare products. The company along with its subsidiaries provides immunoassays, invitro diagnostics, and point of care PoC tests to life sciences, bioseparation, clinical diagnostic, and medical device markets, including a PoC test for the diagnosis of heart attacks troponin test. It...

Epigenomics AG ECX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14112017] Prices from USD $250

SummaryEpigenomics AG Epigenomics is a molecular diagnostics company which develops and commercializes invitro diagnostic IVD tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a bloodbased test for rapid detection of colorectal cancer; and Epi proLung BL Reflex assay, a validating test for the diagnosis of lung cancer. The company's molecular diagnosti...

Co-Diagnostics, Inc. to Present at the Lytham Partners Virtual Investor Conference on November 30, 2017 at 2:00 p.m. ET

Management to Review Investor Presentation and Conduct Q&A; Replay Available on Demand Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced that Dwight Egan, chief executive officer of Co-Diagnostics, will present at the Lytham Partners Virtual ...

Piper Jaffray to Host 29th Annual Healthcare Conference

Piper Jaffray Companies (NYSE: PJC), a leading investment bank and asset management firm, will host its 29th annual Healthcare Conference in New York on November 28-29, 2017. The Piper Jaffray Healthcare Conference will showcase senior management teams from nearly 275 leading public and private companies delivering presentations to an audie...

Reliance Life Sciences Pvt Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 15112017] Prices from USD $250

SummaryReliance Life Sciences Pvt Ltd Reliance Life Sciences, a subsidiary of Reliance Industries Limited, is a biotechnology company which manufactures and develops medical products for healthcare industry. The company's product portfolio includes plasma proteins, biosimilars, proteins, steroid, hormones, Active Pharmaceutical Ingredients API and Finished Dosage Forms FDFs and others. It also pro...

New Sponsored Webinar Showcases the Emergence of Clinical Proteomics

LabRoots will host the webinar December 14, during which attendees will learn the clinical impact on delivering much needed biomarkers of therapeutic response. YORBA LINDA, Calif. (PRWEB) November 22, 2017 The benefits of genomic analysis are well understood, however, the majority of patients do not harbor druggable alterations in their genomes and thus are not candidates for targeted therapies. ...

France Hemostasis Diagnostics Market 2021: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers [Report Updated: 15112017] Prices from USD $6100

Complete report $6,100. nbsp;DataPack test volumes, sales forecasts, supplier shares $3,950.SummaryThis comprehensive report contains 405 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the French coagulation testing market during the next five years.The report explores business and technological tre...

Global and China Hearing Diagnostic Devices Market Research by Company, Type Application 20132025 [Report Updated: 13112017] Prices from USD $2000

SummaryMarket Segment as follows:By Type OAE Audiometer Otoscope Tympanometer OthersBy Application Household Special OrganizationBy Company William Demant MAICO Diagnostics Amplivox Welch Allyn Otometrics Grason Stadler Interacoustics INVENTIS RION Natus Medical IncorporatedThe main contents of the report including:Section 1:Product definition, ty...

Global Glycomics/Glycobiology Market Research Report 20112023 [Report Updated: 10112017] Prices from USD $2450

SummaryGlycomics is the comprehensive study of glycomes the entire complement of sugars, whether free or present in more complex molecules of an organism, including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix ...

EKF launches new POC Connect mobile app for DiaSpect Tm hemoglobin analyzer

EKF Diagnostics, the global in vitro diagnostics company, today introduces POC Connect - a data management smartphone application for its DiaSpect Tm hemoglobin analyzer.

Tuesday 21st November 2017

PerkinElmer to Present at Citi Global Healthcare Conference

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Citi Global Healthcare Conference on Wednesday, December 6, 2017 10:15 a.m. ET at the Lotte New York Palace in New York City. Andy Wilson, PerkinElmer’s chief financial officer, will provide an ...

Illumina Wins Infringement Suit Against Premaitha Health plc and Ariosa Diagnostics, Inc.

Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Premaitha Health plc, et al. and the patent infringement suit filed against Ariosa Diagnostics, Inc., et al. The Court found that Premaitha...

GE Healthcare Earns ONC Health IT Certification from Drummond Group LLC, Improves Interoperability in Workflows

GE Healthcare today announced that Centricity Practice Solution and Centricity Electronic Medical Record (EMR) have been certified to the ONC 2015 Edition certification criteria, the most recent ONC criteria available. This certification will assist eligible healthcare professionals and clinicians in attesting for Stage 3 Meaningful Use measures and fully ...

Top 5 Vendors in the Tuberculosis Diagnostics Market from 2017 to 2021 | Technavio

Technavio has announced the top five leading vendors in their recent global tuberculosis (TB) diagnostics market report. This research report also lists 12 other prominent vendors that are expected to impact the market during the forecast period. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171...

FDA treads carefully on molecular diagnostics

FDA approval would set a molecular test apart, said Vince Miller, Foundation Medicine’s chief medical officer. “CLIA is the floor, New York State is a number of floors above that and the FDA is the penthouse.”

Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference

OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that Peter Wrighton-Smith, Chief Executive Officer, will present at the 29th Annual Pipe...

Biogen Finds Clancy’s Replacement, Names Capello New CFO

Biogen (NASDAQ: [[ticker:BIIB]) has named Jeffrey Capello its new executive vice president and chief financial officer. Capello, a former Boston Scientific, Ortho Clinical Diagnostics, and PerkinElmer executive, will start on December 11. Biogen has been searching for a CFO ever since Paul Clancy, who spent more than 16 years at the company, left in June […]

Riverain Technologies Integrates ClearRead CT with Nuance PowerScribe 360

Riverain Technologies announces that it has integrated its ClearRead CT reporting with the Nuance PowerScribe 360 reporting and visualization tools. As Riverain’s ClearRead CT install base continues to expand and customers implement enterprise level solutions, tighter integration into reporting tools is critical for optimized workflows. C...

Asuragen to Present at 29th Annual Piper Jaffray Healthcare Conference

Asuragen, Inc., a global molecular diagnostics product company changing the way patients are treated in genetics and oncology by bringing complex molecular tests to hospital and reference labs, announced that Matthew McManus, M.D., Ph.D., president and chief executive officer, will present at the 29th Annual Piper Jaffray Healthcare Conference on Wednesday...


Quick Search
Advertisement
 

News Quicklinks